Home-Based tDCS Treatment Of Major Depressive Disorder
RecruitingNCT06976697Phase: NAStarted 2025-06-27
Summary
The REACH-tDCS study will evaluate the safety and efficacy of a noninvasive, at-home self-administered Sooma tDCS brain stimulation treatment for Major Depressive Disorder. The study uses randomized,
Eligibility
Sex
ALL
Min Age
22 Years
Max Age
70 Years
Locations
Lindus Health (virtual study site)Boston, Massachusetts, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06976697